Drw Securities, LLC Adverum Biotechnologies, Inc. Transaction History

Drw Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$5.1 - $11.89 $102,510 - $238,989	-20,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.03 - $6.02 $60,902 - $121,001	20,100 New	20,100 $105,000
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $180,000 - $304,000	-40,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $79,500 - $103,500	15,000 Added 60.0%	40,000 $212,000
Q1 2018 May 14, 2018	SELL	$3.65 - $7.95 $18,250 - $39,750	-5,000 Reduced 16.67%	25,000 $145,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $85,500 - $118,500	30,000	30,000 $105,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $612M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.